A retrospective study evaluating activity of Sunitinib in homogenous international cohort of metastatic chromophobe renal cell carcinoma patients.
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 17 Nov 2017 New trial record